Bio-Rad Laboratories, Inc.

Healthcare · Medical - Devices

Overall research band Mixed

Quality Weak

Valuation Mixed

Balance sheet Very weak

Market confirmation Exceptional

One-minute company read

What this report can tell you now

What the company does

Bio-Rad Laboratories, Inc., founded in 1952 and headquartered in Hercules, California, is a global provider of life science research and clinical diagnostic products. The company operates through two main divisions: Life Science, which develops and sells reagents, equipment, and laboratory instruments for research, biopharmaceutical manufacturing, and food quality testing; and Clinical Diagnostics, which offers test systems, diagnostic kits, quality control products, and informatics solutions for clinical laboratories. Bio-Rad serves a diverse customer base including academic institutions, industrial research organizations, government agencies, pharmaceutical and biotechnology companies, food producers, and clinical laboratories. Its revenue model is based on the sale of specialized products and systems through both direct sales and third-party distributors.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC2.6%Model input; read with the evidence status and period context.

Operating margin10.5%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years-3.0%Model input; read with the evidence status and period context.

FCF margin14.5%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.